Research graph
References from Combined Effects of Biomarkers in NLRP3 Inflammasome Axis and Cardiovascular Outcomes in Multivessels Disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Multi-vessel coronary disease and percutaneous coronary intervention
10.1136/hrt.2003.018986 · 2004 · External reference
10.1016/j.jacc.2011.02.074
10.1016/j.jacc.2011.02.074 · 2011 · External reference
Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention
10.1016/j.jjcc.2019.06.012 · 2020 · External reference
Predictive value of in-hospital white blood cell count in Chinese patients with triple-vessel coronary disease
10.1177/2047487319826398 · 2019 · External reference
Targeting the NLRP3 inflammasome in cardiovascular diseases
10.1016/j.pharmthera.2021.108053 · 2022 · External reference
NLRP3 inflammasome and the IL-1 pathway in atherosclerosis
10.1161/circresaha.118.311362 · 2018 · External reference
Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: atherosclerosis risk in communities study
10.1093/eurjpc/zwad197 · 2023 · External reference
All roads lead to IL-6: a central hub of cardiometabolic signaling
10.1016/j.ijcard.2018.02.062 · 2018 · External reference
Interleukin-1β and risk of premature death in patients with myocardial infarction
10.1016/j.jacc.2020.08.026 · 2020 · External reference
Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome
10.1001/jamacardio.2021.3079 · 2021 · External reference
Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina
10.1161/01.cir.0000020546.30940.92 · 2002 · External reference
Association of initial and serial C-Reactive protein levels with adverse cardiovascular events and death after acute coronary syndrome: a secondary analysis of the VISTA-16 trial
10.1001/jamacardio.2019.0179 · 2019 · External reference
Clinician's guide to reducing inflammation to reduce atherothrombotic risk: JACC review topic of the week
10.1016/j.jacc.2018.06.082 · 2018 · External reference
The expression of SAH, IL-1β, Hcy, TNF-α and BDNF in coronary heart disease and its relationship with the severity of coronary stenosis
10.1186/s12872-021-02388-6 · 2022 · External reference
Interleukin 6 plasma levels are associated with progression of coronary plaques
10.1136/openhrt-2024-002773 · 2024 · External reference
Promises and challenges of targeting inflammation to treat cardiovascular disease: the post-CANTOS era
10.1093/eurheartj/ehz586 · 2020 · External reference
Antiinflammatory therapy with canakinumab for atherosclerotic disease
10.1056/nejmoa1707914 · 2017 · External reference
Efficacy and safety of low-dose colchicine after myocardial infarction
10.1056/nejmoa1912388 · 2019 · External reference
Colchicine in patients with chronic coronary disease
10.1056/nejmoa2021372 · 2020 · External reference
Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis
10.1093/eurheartj/ehz542 · 2020 · External reference
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
10.1093/eurheartj/ehw171 · 2016 · External reference
Randomized trial of Interleukin-6 receptor inhibition in patients with acute ST-Segment elevation myocardial infarction
10.1016/j.jacc.2021.02.049 · 2021 · External reference
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
10.1016/s0140-6736(21)00520-1 · 2021 · External reference
The protective role of interleukin-18 binding protein in a murine model of cardiac ischemia/reperfusion injury
10.1111/tri.12683 · 2015 · External reference
Modulation of Interleukin-1 and -18 mediated injury in donation after circulatory death mouse hearts
10.1016/j.jss.2020.08.020 · 2021 · External reference
